METABOLIC DISEASE

1 minute read

Mar. 12, 2022

GCC5694A

oral SGLT2 inhibitor Clinical candidate for diabetes from literature SGLT2 inhibitor Bioorganic Med. Chem. Lett. GC Pharma (Green Cross)

Drug Hunter Team

Other molecules you may be interested in